Kyverna Therapeutics Inc. (KYTX)
3.29
-0.04 (-1.20%)
At close: Jan 15, 2025, 3:59 PM
3.29
-0.03%
After-hours Jan 15, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 |
| Cash & Equivalents | 34.65M | 37.73M | 76.07M |
| Short-Term Investments | 22.90M | 13.59M | n/a |
| Long-Term Investments | n/a | 554.00K | 552.00K |
| Other Long-Term Assets | 3.92M | 678.00K | 41.00K |
| Receivables | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a |
| Other Current Assets | 3.12M | 1.93M | 1.02M |
| Total Current Assets | 60.66M | 53.25M | 77.09M |
| Property-Plant & Equipment | 10.61M | 12.44M | 7.81M |
| Goodwill & Intangibles | n/a | n/a | n/a |
| Total Long-Term Assets | 14.53M | 13.67M | 8.40M |
| Total Assets | 75.19M | 66.92M | 85.49M |
| Account Payables | 4.36M | 1.45M | 773.00K |
| Deferred Revenue | n/a | 7.66M | 6.00M |
| Short-Term Debt | 2.92M | 2.28M | 814.00K |
| Other Current Liabilities | 12.58M | 8.23M | 8.34M |
| Total Current Liabilities | 19.86M | 11.95M | 15.93M |
| Long-Term Debt | 6.16M | 8.29M | 4.74M |
| Other Long-Term Liabilities | n/a | 120.68M | 78.00K |
| Total Long-Term Liabilities | 6.16M | 128.97M | 115.81M |
| Total Liabilities | 26.02M | 140.92M | 131.74M |
| Total Debt | 9.08M | 10.56M | 5.55M |
| Common Stock | n/a | n/a | n/a |
| Retained Earnings | -136.04M | -75.68M | -46.78M |
| Comprehensive Income | 4.00K | -26.00K | n/a |
| Shareholders Equity | 49.18M | -74.00M | -46.25M |
| Total Investments | 22.90M | 13.59M | 552.00K |